Chatham Rock Phosphate: Slowing Momentum

 | Aug 23, 2013 01:15AM ET

Delays and funding squeeze bite

Since our last update in May, Chatham Rock Phosphate’s (CRP) momentum has slowed. Delays to regulatory approval processes have weighed on confidence and investor sentiment. Following a soft result from a recent public offer, CRP has launched a new success-linked share offer to bridge it to and beyond separate consenting and approval processes. Our unrisked valuation rises slightly to NZ$2.04/share.